{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:06:05Z","timestamp":1794488765210,"version":"4.9.1"},"reference-count":78,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019533","name":"Moderna, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/13696998.2026.2624967","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:05:12Z","timestamp":1772723112000},"page":"574-593","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["Modeling the cost-effectiveness of the next-generation COVID-19 mRNA-1283 vaccine in the United States"],"prefix":"10.1080","volume":"29","author":[{"given":"Kelly","family":"Fust","sequence":"first","affiliation":[{"name":"Quadrant Health Economics, Inc","place":["Cambridge, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Kohli","sequence":"additional","affiliation":[{"name":"Quadrant Health Economics, Inc","place":["Cambridge, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keya","family":"Joshi","sequence":"additional","affiliation":[{"name":"Moderna, Inc","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Cartier","sequence":"additional","affiliation":[{"name":"Quadrant Health Economics, Inc","place":["Cambridge, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Lee","sequence":"additional","affiliation":[{"name":"Quadrant Health Economics, Inc","place":["Cambridge, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Van de Velde","sequence":"additional","affiliation":[{"name":"Moderna, Inc","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Weinstein","sequence":"additional","affiliation":[{"name":"Harvard T.H. Chan School of Public Health","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Beck","sequence":"additional","affiliation":[{"name":"Moderna, Inc","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"e_1_3_7_2_1","unstructured":"Centers for Disease Control and Prevention. Preliminary estimates of COVID-19 burden for 2024\u20132025. [cited 2025 May 19]. Available from: https:\/\/www.cdc.gov\/covid\/php\/surveillance\/burden-estimates.html."},{"key":"e_1_3_7_3_1","unstructured":"Centers for Disease Control and Prevention. Underlying conditions and the higher risk for severe COVID-19 2025. [cited 2025 May 12]. Available from https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/underlying-conditions.html."},{"key":"e_1_3_7_4_1","unstructured":"MacNeil A. Evidence to Recommendations (partial) for 2025\u20132026 COVID-19 Vaccination. Presentation to the Advisory Committee on Immunization Practices. [cited 2025 Jun 25]. Available from: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2025-06-25-26\/06-MacNeil-COVID-508.pdf."},{"key":"e_1_3_7_5_1","unstructured":"Centers for Disease Control and Prevention. Updates to COVID-19 epidemiology. Advisory Committee on Immunization Practices. 2025 [cited 2025 Nov 6]. Available from: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2025-09-18-19\/02-Srinivasan-covid-508.pdf."},{"key":"e_1_3_7_6_1","unstructured":"Centers for Disease Control and Prevention. COVID-19 vaccination coverage and intent for vaccination adults 18 years and older United States. [cited 2025 May 19]. Available from https:\/\/www.cdc.gov\/covidvaxview\/weekly-dashboard\/adult-vaccination-coverage.html."},{"key":"e_1_3_7_7_1","unstructured":"Centers for Disease Control and Prevention. Flu vaccination coverage United States 2023\u201324 Influenza Season. [cited 2025 May 19]. Available from https:\/\/www.cdc.gov\/fluvaxview\/coverage-by-season\/2023-2024.html."},{"key":"e_1_3_7_8_1","unstructured":"Food and Drug Administration (FDA). mNEXSPIKE. [cited 2025 Jul 7]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/mnexspike."},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00236-1"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2023.11.023"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf4100"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11111711"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115463"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2022.2109"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-00936-z"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-025-03117-7"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.127960"},{"key":"e_1_3_7_18_1","unstructured":"ModernaTX Inc. MNEXSPIKE Full Prescribing Information 2025. [cited 2026 January 22]. Available from: https:\/\/www.fda.gov\/media\/186738\/download?attachment."},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2025.2466726"},{"key":"e_1_3_7_20_1","unstructured":"US Department of Health and Human Services. ACIP Recommends COVID-19 Immunization Based on Individual Decision-making. 2025 [cited 2025 Nov 6]. Available from: https:\/\/www.hhs.gov\/press-room\/acip-recommends-covid19-vaccination-individual-decision-making.html."},{"key":"e_1_3_7_21_1","unstructured":"Center for Disease Control and Prevention. Vaccines & immunizations. Adult Immunization Schedule Appendix. [cited 2025 Nov 6]. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-schedules\/adult-appendix.html."},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1101\/2025.09.26.25336704"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.23688"},{"key":"e_1_3_7_24_1","unstructured":"University of Michigan COVID-19 Vaccination Modeling Team. Economic analysis of an additional dose of the 2024\u20132025 COVID-19 vaccine. Presentation to the Advisory Committee on Immunization Practices 2024. [cited 2025 Nov 6]. Available from https:\/\/www.cdc.gov\/acip\/downloads\/slides-2024-10-23-24\/05-COVID-Prosser-508.pdf."},{"key":"e_1_3_7_25_1","unstructured":"Center for Disease Control and Prevention. Vaccines & immunizations. Adult Immunization Schedule by Age; 2025. [cited 2025 Nov 6]. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/imz-schedules\/adult-age.html"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7349a2"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.1792"},{"key":"e_1_3_7_28_1","unstructured":"ASPE Office of Science and Data Policy. HHS standard values for regulatory analysis; 2025 [cited 2025 Nov 6]. Available from: https:\/\/aspe.hhs.gov\/sites\/default\/files\/documents\/639756a60fbe7e51786bcec176ad52f1\/Standard-RIA-Values-2025.pdf"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2025.2549630"},{"key":"e_1_3_7_30_1","unstructured":"United Nations Department of Economic and Social Affairs (Population Division). World Population Prospects 2024. 2024 [cited 2024 Sep 3]. Available from: https:\/\/population.un.org\/wpp\/downloads?folder=Standard%20Projections&group=Population."},{"key":"e_1_3_7_31_1","unstructured":"Food and Drug Administration. MNEXSPIKE. [cited 2025 July 7]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/mnexspike"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.11182"},{"key":"e_1_3_7_33_1","unstructured":"Panagiotakopoulos L. Use of 2025\u20132026 COVID-19 vaccines: work group considerations. Presentation to the Advisory Commitee on Immunization Practices; 2025 [cited 2025 May 5]. Available from: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2025-04-15-16\/05-Panagiotakopoulos-COVID-508.pdf"},{"key":"e_1_3_7_34_1","unstructured":"Centers for Disease Control and Prevention. COVID-NET. COVID-19 Hospitalization Surveillance Network; 2024 [cited 2024 May 6]. Available from: https:\/\/www.cdc.gov\/covid\/php\/covid-net\/index.html?CDC_AA_refVal=https%3A\/\/www.cdc.gov\/coronavirus\/2019-ncov\/covidnetdashboard\/de\/powerbi\/dashboard.html"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.04.069"},{"key":"e_1_3_7_36_1","unstructured":"Centers for Disease Control and Prevention. Weekly Cumulative COVID-19 VACCINATION coverage and intent overall by selected demographics and jurisdiction among adults 18 years and older; 2025 [cited 2025 Feb 28]. Available from: https:\/\/data.cdc.gov\/Vaccinations\/Weekly-Cumulative-COVID-19-Vaccination-Coverage-an\/ksfb-ug5d\/about_data."},{"key":"e_1_3_7_37_1","unstructured":"Centers for Disease Control and Prevention. Weekly parental intent for vaccination and cumulative percentage of children 6 months \u221217 years who are up to date with the COVID-19 Vaccines by Season United States; 2025 [cited 2025 Feb 28]. Available from: https:\/\/www.cdc.gov\/covidvaxview\/weekly-dashboard\/child-coverage-vaccination.html."},{"key":"e_1_3_7_38_1","unstructured":"County of Los Angeles Public Health. COVID-19 Vaccine: vaccinations in LA County. [cited 2025 Nov 6]. Available from: http:\/\/publichealth.lacounty.gov\/media\/coronavirus\/vaccine\/vaccine-dashboard.htm."},{"key":"e_1_3_7_39_1","unstructured":"Moderna Inc. mRNA-1283 P301 Clinical Study Report."},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.27.25324770"},{"key":"e_1_3_7_41_1","unstructured":"MacNeil A. Updates to COVID-19 vaccine effectiveness. Presentation to the Advisory Committee on Immunization Practices; 2025. [cited 2025 Jun 25]. Available from: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2025-06-25-26\/03-MacNeil-COVID-508.pdf."},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2024-001074"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12101107"},{"key":"e_1_3_7_44_1","volume-title":"An Indirect Treatment Comparison of COVID-19 Next Generation mRNA-1283 Vaccine and BNT162b2 Vaccine Against COVID-19 Symptomatic Infections in the US","author":"Beck E","year":"2025","unstructured":"Beck E, Georgieva M, Wang W, et al., editors. An Indirect Treatment Comparison of COVID-19 Next Generation mRNA-1283 Vaccine and BNT162b2 Vaccine Against COVID-19 Symptomatic Infections in the US. Houston, TX: AMCP; 2025."},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-022-01272-z"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-024-01072-4"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1101\/2025.08.01.25332812"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00409-1"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00380-9"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.5258507"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae695"},{"key":"e_1_3_7_52_1","unstructured":"Moderna data on file 2024. Optum\u2019s de-identified Clinformatics\u00ae Data Mart Database. Analysis September 2023 to February 2024 COVID-19 medical attendances and hospitalizations."},{"key":"e_1_3_7_53_1","unstructured":"Moderna. COVID-19 Hospitalization Risk by Comorbidities Profile (Risk Stacking). Moderna bench to practice website. Available from: https:\/\/dev.atlas.modernatx.com\/bench2practice\/Interactive-dashboard."},{"key":"e_1_3_7_54_1","unstructured":"University of Michigan COVID-19 Vaccination Modeling Team. Economic analysis of COVID-19 vaccination. 2024 [cited 2025 Feb 19]. Available from: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2024-06-26-28\/05-COVID-Prosser-508.pdf."},{"key":"e_1_3_7_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-025-01128-z"},{"key":"e_1_3_7_56_1","unstructured":"Centers for Disease Control and Prevention. Post-COVID conditions. 2025 [cited 2025 Nov 6]. Available from: https:\/\/data.cdc.gov\/National-Center-for-Health-Statistics\/Post-COVID-Conditions\/gsea-w83j\/about_data."},{"key":"e_1_3_7_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.10.059"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.3390\/children12020181"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00127-8"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.12195"},{"key":"e_1_3_7_61_1","unstructured":"Arias E. United States Life Tables 2017 (National Vital Statistics Report); 2019. [cited 2025 Dec 2]. Available from: https:\/\/stacks.cdc.gov\/view\/cdc\/79487."},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06290497"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2024.2416873"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.50145"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2023.89452"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-03235-5"},{"key":"e_1_3_7_67_1","unstructured":"Center for Disease Control and Prevention. Vaccines for Children Program. Current CDC Vaccine Price List; 2025 [updated November 1 2025; cited 2025 Nov 3]. Available from: https:\/\/www.cdc.gov\/vaccines-for-children\/php\/awardees\/current-cdc-vaccine-price-list.html."},{"key":"e_1_3_7_68_1","unstructured":"Centers for Medicare & Medicaid Services. National Physician Fee Schedule Relative Value File October Release; 2025 [cited 2025 Oct 6]. Available from: https:\/\/www.cms.gov\/medicare\/payment\/fee-schedules\/physician\/pfs-relative-value-files\/rvu25d-0."},{"key":"e_1_3_7_69_1","unstructured":"Centers for Medicare & Medicaid Services. Vaccine Pricing. [cited 2024 Sep 19]. Available from https:\/\/www.cms.gov\/medicare\/payment\/part-b-drugs\/vaccine-pricing."},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-023-01653-z"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1542520"},{"key":"e_1_3_7_72_1","unstructured":"University of Michigan COVID-19 Vaccination Modeling Team. Economic Analysis of COVID-19 Vaccination. Presentation to the Advisory Committee on Immunization Practices 2025 [cited 2025 Dec 2]. Available from: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2025-09-18-19\/08-Srinivasan-covid-508.pdf."},{"key":"e_1_3_7_73_1","unstructured":"Ortega-Sanchez IR. Economics of respiratory syncytial virus vaccination in adults aged 50\u201359 years at increased risk of severe RSV disease. [cited 2025 Apr 16]. Available from: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2025-04-15-16\/05-Ortega-Sanchez-Adult-RSV-508.pdf"},{"key":"e_1_3_7_74_1","unstructured":"Leidner AJ Bletnitsky S. Summary of three economic analyses on the use of PCVs among 50\u201364 year old adults in the United States; 2024 [cited 2025 May 15]. Available from: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2024-10-23-24\/03-Leidner-Pneumococcal-508.pdf"},{"key":"e_1_3_7_75_1","article-title":"CDC National Center for Immunization and Respiratory Diseases","author":"Link-Gelles R.","year":"2024","unstructured":"Link-Gelles R. CDC National Center for Immunization and Respiratory Diseases. Effectiveness of COVID-19 (2023\u20132024 Formulation). 2024 [cited 2024 Jun 27]. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2024-06-26-28\/03-COVID-Link-Gelles-508.pdf","journal-title":"Effectiveness of COVID-19 (2023\u20132024 Formulation)"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.27.25324770"},{"key":"e_1_3_7_77_1","unstructured":"Rizkalla B. Overview of Moderna\u2019s Investigational Next Generation COVID-19 vaccine. mRNA-1283 in individuals 2025. [cited 2025 Apr 15]. Available from: https:\/\/www.cdc.gov\/acip\/downloads\/slides-2025-04-15-16\/02-Rizkalla-COVID-508.pdf."},{"key":"e_1_3_7_78_1","unstructured":"Tan NH Geers D Sablerolles RSG et al. Evaluation of bivalent Omicron BA.1 booster vaccination after different priming regimens in healthcare workers (SWITCH ON): a randomized controlled trial. medRxiv; 2022:2022.12.18.22283593."},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abm3087"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2026.2624967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:59:24Z","timestamp":1773302364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2026.2624967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/13696998.2026.2624967"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2026.2624967","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}